Anti-Cancer Drugs 2 Flashcards
Where does the production of androgen occur in males?
testes
what are our drugs to treat prostate cancer?
Leuprolide/Goserelin
Degareliz
Flutamide
Leuprolide/goserelin
MOA
Side effects
Leuprolide/goserelin
- MOA: GnRH agonists. An initial surge in LH increases testosterone production causing a downregulation of GnRH receptors and a decline in pituitary response (a negative feedback). after 3-4 weeks the decrease in serum LH leads to decreased testosterone production
- SE:
- bone pain, urinary obstruction
- Androgen deprivation effects
degarelix
MOA
Side Effects
Degarelix
- MOA: suppress testosterone (GnRH antagonist)
- SE:
- Androgen deprivation effects: decreased libido; ED
- gynecomastia
- Hot flashes
- decreased muscle mass and strength
- hyperglycemia
** androgen deprivation effects basically turn you into a golden girl
Flutamide
MOA
Side Effects
Flutamide
- MOA: antagonist of the androgen receptor
- binds to androgen receptor and competitively inhibits the binding of testosterone and DHT
- normal testosterone level
- SE:
- gynecomastia
- Hepatic Failure
Targetet Therapy
BRC-ABL inhibitor
imatinib
Targeted Therapy
mTOR inhibitors
Rapamycin
Targeted Therapy
BRAF inhibitor
Vemurafenib
Targeted Therapy
HER2 inhibitor
Trastuzumab
Targeted Therapy
EGFR inhibitor
Erlotinib
Targeted Therapy
VEGF inhibitor
Bevacizumab
Targeted Therapy
multi-kinase inhibitor
Crizotinib
Imatinib
MOA
Side Effects
Imatinib- CML that have the t(9;22) chromosome
- MOA: competitively binds ATP binding site and inhibits tyrosine phosporylation of BCR-ABL kinase
- Side effects:
- N/V/D
- fluid retention/edema
- cardiovascular toxicity
- myalgias
Rapamycin (sirolimus) and Everolimus
MOA
Clinical Use
Rapamycin (sirolimus) and Everolimus
- MOA:
- mTOR inhibitor
- PI3K/AKT pathway is inhibited
- mTOR inhibitor
- CU:
- prevention of rejection after transplant
- Everolimus is used in renal, breast, and GI cancers
2.
- Everolimus is used in renal, breast, and GI cancers
- prevention of rejection after transplant
Rituximab
MOA
CU
SE
Rituximab
- MOA:
- antibody against CD20
- CU:
- CD20 (+) B cell NHL, CLL
- immune diseases- RA, ITP, Wegener’s granulomatosis
- SE:
- anemia
- hypotension
- GI disturbances
- skin reactions